Picture walking into your office one morning and finding an official HRSA audit notification waiting in your inbox. Your heart skips a beat because you know what this means for your organization. The 340B Drug Pricing Program has become a lifeline for healthcare providers serving vulnerable populations, but with great benefits come equally significant responsibilities.
Consider this sobering reality: in 2023, the program reached an unprecedented $66.3 billion in drug purchases, yet recent data shows that 70% of covered entities face adverse audit findings. These aren’t small oversights we’re talking about. Organizations can lose their 340B status entirely or face massive financial penalties that threaten their ability to serve their communities.
What you’ll find in this guide goes beyond basic compliance tips. We’ll walk through every aspect of audit preparation, from the documentation you absolutely must have ready to the common pitfalls that trip up even experienced healthcare administrators. By the time you finish reading, you’ll have a clear roadmap for protecting your organization’s 340B eligibility while maximizing the program’s benefits for your patients.
What is a 340B Audit?
Think of a 340B audit as an intensive health checkup for your drug pricing program compliance. When HRSA or manufacturer-appointed auditors arrive at your facility, they’re essentially conducting a thorough examination of how well you’ve followed federal regulations. This process typically unfolds over several weeks and includes both paperwork reviews and on-site visits where auditors verify that your actual practices match your documented policies.
The audit serves as the federal government’s primary tool for ensuring that the 340B program operates as Congress intended back in 1992. Since the program allows qualifying healthcare organizations to purchase medications at heavily discounted rates, auditors must verify that these savings truly benefit eligible patients rather than generating inappropriate profits. Every discounted drug must reach a qualified patient through an approved dispensing method.
What makes these audits particularly challenging is their comprehensive scope. Auditors examine everything from individual patient relationships to your organization’s contract pharmacy agreements. Recent regulatory shifts have made HRSA’s standards increasingly strict, which means practices that passed muster five years ago might now result in significant violations.
Why You Need a 340B Audit Checklist
Organizations that approach audits without systematic preparation often face consequences that extend far beyond temporary inconvenience. When covered entities fail compliance requirements, they risk complete removal from the 340B program. For many safety-net providers, this means losing access to medication discounts worth millions of dollars annually. The financial impact can force service reductions or even facility closures in communities that desperately need healthcare access.
The stakes have grown higher as the program has expanded dramatically. Between 2022 and 2023 alone, 340B purchases jumped from $53.7 billion to $66.3 billion, representing a staggering 23.4% increase in just one year. This rapid growth has attracted intense scrutiny from regulators and pharmaceutical manufacturers, who now conduct more frequent and thorough audits than ever before. Modern covered entities must manage increasingly complex operations involving multiple contract pharmacies, specialty drug programs, and diverse patient populations across numerous locations.
Recent audit statistics paint a concerning picture for unprepared organizations. In fiscal year 2023, 63% of audited covered entities received adverse findings, with violations typically involving patient eligibility errors, poor record-keeping, and contract pharmacy management failures. These numbers represent a clear trend toward stricter enforcement that shows no signs of slowing down.
However, organizations that invest in comprehensive audit preparation often discover that the benefits far outweigh the costs. Proper preparation reduces audit duration, minimizes adverse findings, and creates stronger compliance cultures that prevent violations before they occur. The time and resources invested in systematic preparation typically pale in comparison to the costs of remediation after audit failures.
340B Audit Checklist
Effective audit preparation requires systematic documentation across all areas of program compliance. This checklist covers the essential elements that auditors will examine during both their initial document review and subsequent on-site verification activities.
Patient Eligibility and Definition
- Patient relationship documentation demonstrating established healthcare provider-patient relationships
- Medical records proving patients received qualifying healthcare services beyond drug dispensing
- Provider employment or contractual documentation for all prescribing healthcare professionals
- Patient encounter records showing services consistent with covered entity’s scope of federal funding
- Written policies defining patient eligibility criteria consistent with HRSA guidance
- Documentation of patient eligibility verification procedures for all dispensing locations
- Records demonstrating patient geographic service area compliance requirements
- Evidence of ongoing patient care relationships rather than one-time prescription-only encounters
Drug Inventory and Purchasing Records
- Complete 340B drug purchasing documentation with manufacturer pricing verification
- Inventory tracking systems demonstrating proper segregation of 340B and non-340B drugs
- Dispensing records linking specific drug lots to eligible patient prescriptions
- Wholesaler purchase agreements and invoicing documentation
- Drug return, destruction, and waste disposal documentation
- Specialty drug handling and distribution records
- Emergency drug supply protocols and documentation
- Physical inventory verification and reconciliation procedures
Contract Pharmacy Management
- Fully executed contract pharmacy agreements meeting current HRSA requirements
- Contract pharmacy registration documentation in HRSA’s 340B Prime Vendor Program
- Written policies governing contract pharmacy drug dispensing procedures
- Regular contract pharmacy compliance monitoring and audit documentation
- Contract pharmacy fee arrangements and financial documentation
- Drug shipment and transfer documentation between covered entities and contract pharmacies
- Contract pharmacy staff training records and competency verification
- Termination procedures and documentation for non-compliant contract pharmacy relationships
Duplicate Discount Prevention
- Medicaid billing procedures preventing duplicate discount claims
- State Medicaid agency coordination documentation and reporting protocols
- Insurance claim review procedures identifying Medicaid fee-for-service encounters
- Split billing methodology documentation for mixed payer patient encounters
- Staff training records covering duplicate discount prevention requirements
- Billing system configuration documentation preventing automatic Medicaid billing for 340B drugs
- Monthly reconciliation procedures comparing 340B dispensing with Medicaid claims
- Documentation of duplicate discount identification and correction procedures
Organizational Compliance Structure
- Written 340B program policies and procedures covering all compliance requirements
- Staff training documentation and competency verification for all 340B program participants
- Internal audit schedules and completed audit documentation
- Compliance officer designation and responsibility documentation
- Board oversight documentation and reporting procedures
- Corrective action plan development and implementation procedures
- External consultant agreements and compliance support documentation
- Annual compliance certification and recertification documentation
340B Audit Checklist: Analysis
Understanding the technical requirements alone won’t guarantee audit success. You also need strategic insights into how auditors approach each compliance area and what they’re really looking for during their examinations.
Patient Eligibility and Definition
Patient eligibility forms the cornerstone of 340B compliance, yet it generates some of the most complex and contentious audit findings. HRSA’s patient definition requires much more than simply having someone’s name in your computer system. You must demonstrate an established healthcare relationship where your organization maintains comprehensive patient records, provides healthcare services through employed or contracted providers, and delivers care that aligns with your federal funding purposes.
The challenge lies in HRSA’s increasingly strict interpretation of what constitutes a legitimate patient relationship. Gone are the days when minimal documentation might satisfy auditors. Today’s standards require substantial evidence of ongoing care relationships that extend well beyond prescription writing. Your prescribing providers must have clear employment or contractual ties to your covered entity, and patients must receive services that fall within your scope of federal funding. Smart organizations now conduct quarterly patient eligibility reviews using statistical sampling methods to catch potential compliance gaps before external auditors arrive.
Drug Inventory and Purchasing Records
Your drug inventory management system serves as the operational foundation for demonstrating 340B compliance. Auditors will scrutinize every aspect of your drug lifecycle, from initial purchasing through final patient dispensing. This means maintaining sophisticated tracking systems that document proper 340B pricing, prevent inventory mixing that could lead to diversion, and link specific drug lots to individual patient prescriptions.
Successful inventory management requires automated systems that capture real-time data about manufacturer pricing, wholesaler transactions, and patient-specific dispensing records. Physical inventory procedures must include regular reconciliation between electronic records and actual drug stock on your shelves. The key insight here is that monthly inventory reconciliation procedures help identify discrepancies before they snowball into major audit problems. Organizations that wait for annual inventory counts often discover problems too late to prevent audit violations.
Contract Pharmacy Management
Contract pharmacy relationships have become incredibly complex as the program has expanded to include over 33,000 retail pharmacy locations nationwide. Managing these relationships requires comprehensive agreements that address current HRSA requirements, ongoing monitoring procedures that ensure continued compliance, and clear communication protocols that maintain program integrity across multiple dispensing sites.
Your contract pharmacy agreements must include every element that HRSA currently requires, and you must verify that each pharmacy maintains proper registration status. Regular compliance monitoring becomes essential because pharmacy operations can change quickly, potentially affecting their ability to meet contractual obligations. The strategic approach involves conducting quarterly contract pharmacy reviews using standardized assessment tools that verify both contractual compliance and federal requirement adherence.
Duplicate Discount Prevention
Duplicate discount prevention requires careful coordination between your 340B drug dispensing operations and Medicaid billing procedures. The federal prohibition against receiving both 340B discounts and Medicaid rebates for identical drug transactions creates operational challenges that many organizations struggle to address effectively.
Your billing systems must identify Medicaid fee-for-service encounters, prevent automatic Medicaid billing for 340B drugs, and maintain accurate reconciliation between dispensing records and submitted insurance claims. Staff training becomes critical because billing errors can easily occur when employees don’t understand the interplay between different payment systems. Configure your billing systems with automatic alerts that flag potential Medicaid encounters and require supervisor approval before processing claims for patients receiving 340B medications.
Organizational Compliance Structure
Your organizational compliance framework demonstrates to auditors that 340B compliance receives appropriate attention and resources throughout your organization. Effective compliance programs include comprehensive written policies, regular staff training with competency verification, systematic internal auditing, and clear accountability structures that assign specific responsibilities to qualified personnel.
Modern compliance structures should incorporate board-level oversight with regular reporting, designated compliance officers with sufficient authority and resources, and documentation systems that support both daily operations and audit preparation. Annual compliance calendars help maintain consistent attention to policy reviews, staff training, internal audits, and board reporting throughout the year rather than scrambling when audit notifications arrive.
The Audit Process: Step-by-Step Guide
Understanding how audits actually unfold helps organizations prepare more effectively and respond appropriately to auditor requests throughout the examination process.
• Pre-Audit Notification and Preparation: Your organization receives an engagement letter explaining the audit scope, timeline, and required documentation. This typically provides 30-60 days for preparation. Immediately designate key personnel for auditor communication, compile requested documentation, and establish secure areas for document review during on-site visits.
• Document Submission and Portal Upload: Auditors request comprehensive documentation through secure online portals, including policies, procedures, purchasing records, patient files, and contract agreements. Submit complete, well-organized documentation packages with clear indexing while maintaining backup copies for reference during auditor interviews.
• Introductory Conference and Scope Discussion: Auditors conduct initial teleconferences to clarify expectations, discuss timelines, and identify key personnel for interviews. Prepare detailed organizational charts, process flow documentation, and compliance responsibility matrices to help auditors understand your 340B program structure.
• On-Site or Remote Audit Fieldwork: Auditors examine submitted documentation, interview key personnel, and review sample drug transactions using risk-based selection methods. Provide knowledgeable staff for interviews, maintain professional communication, and document all auditor requests and your responses for future reference.
• Sample Testing and Verification Procedures: Auditors select representative samples of drug transactions, patient encounters, and compliance documentation for detailed examination. Support their testing with readily accessible records, clear explanations of your procedures, and prompt responses to requests for clarification.
• Exit Conference and Preliminary Findings: Auditors present their initial observations during exit conferences but emphasize that final determinations remain subject to supervisor review. Listen carefully to their observations, request clarification about specific concerns, and avoid making commitments about corrective actions until you receive the final report.
• Final Report Receipt and Response Preparation: Your organization receives the final audit report detailing findings, violations, and required corrective actions within specified timeframes. Review findings carefully with legal counsel and compliance experts, prepare comprehensive responses addressing each issue, and develop realistic implementation timelines for required corrections.
Common Mistakes to Avoid
Learning from frequent audit failures helps organizations develop more effective compliance strategies and avoid costly violations that can result in program removal or financial penalties.
• Inadequate Patient Eligibility Documentation: Organizations frequently fail to maintain sufficient documentation proving established healthcare relationships beyond simple prescription dispensing. Implement comprehensive patient encounter documentation systems that capture all qualifying healthcare services, maintain current provider employment records, and regularly verify patient eligibility through systematic review procedures.
• Poor Drug Inventory Segregation: Many covered entities struggle to maintain proper separation between 340B and non-340B drug inventory, leading to diversion violations. Establish both physical and electronic inventory segregation systems, implement regular reconciliation procedures, and train staff on proper drug handling protocols that prevent accidental mixing.
• Incomplete Contract Pharmacy Oversight: Organizations often execute contract pharmacy agreements without implementing adequate monitoring procedures for ongoing compliance. Develop systematic contract pharmacy audit programs, maintain regular communication with pharmacy partners, and establish clear performance standards with enforcement mechanisms for non-compliance.
• Insufficient Duplicate Discount Prevention: Covered entities frequently lack comprehensive procedures for preventing simultaneous 340B discounts and Medicaid rebates on identical transactions. Configure billing systems with automatic duplicate discount prevention capabilities, train staff on proper billing procedures, and implement monthly reconciliation procedures that identify and correct any duplicate discount occurrences.
• Weak Internal Audit Programs: Many organizations conduct superficial internal audits that fail to identify significant compliance gaps before external audits discover them. Establish comprehensive internal audit programs using statistical sampling methods, engage external compliance experts for independent reviews, and implement systematic corrective action procedures that address identified deficiencies.
• Inadequate Staff Training: Covered entities often provide minimal 340B training that fails to ensure staff competency in complex compliance requirements. Develop role-specific training programs with competency verification, provide regular updates covering regulatory changes, and maintain comprehensive training documentation that demonstrates staff qualifications for 340B responsibilities.
• Poor Record Retention: Organizations frequently fail to maintain comprehensive documentation that supports compliance verification during multi-year audit periods. Implement systematic record retention policies that exceed minimum legal requirements, establish secure document storage systems, and maintain readily accessible documentation that supports rapid audit response capabilities.
Wrap-Up
Preparing for 340B audits requires comprehensive planning, systematic documentation, and consistent attention to compliance details across all program operations. Organizations that implement thorough audit readiness protocols significantly reduce their risk of adverse findings while protecting access to substantial drug savings that enable continued service to vulnerable patient populations.
The investment in comprehensive compliance programs consistently delivers returns through reduced audit stress, faster resolution of regulatory inquiries, and stronger program integrity that prevents costly violations. Rather than waiting for audit notifications to arrive, smart organizations begin preparation immediately because effective compliance represents an ongoing commitment rather than crisis management.
Start today by conducting a comprehensive gap analysis using this checklist, implementing systematic compliance monitoring procedures, and establishing regular internal audit schedules that maintain continuous readiness for external examination. Your organization’s 340B program sustainability and your patients’ continued access to affordable medications depend on maintaining exemplary compliance standards consistently over time.